They trust us
Research and development of pharmaceuticals and biotechnologies for various diseases, including cardiovascular, renal, and metabolic diseases.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: April 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
GlaxoSmithKline France
A
Research and development of pharmaceuticals in respiratory, immunological, inflammatory diseases, oncology, HIV, and infectious diseases.
Amgen France
B
Research, development, and manufacturing of innovative therapies for serious diseases using biotechnology.
GSK
A
Research and development of pharmaceuticals and vaccines focusing on respiratory, immunology, oncology, HIV, and infectious diseases.
Initiatives identified among leaders
Collaboration avec des organisations pour accélérer la découverte de traitements contre des maladies infectieuses
“Collaboration avec des organisations pour accélére...” - GSKRéduction des émissions de gaz à effet de serre
“GlaxoSmithKline France a pour objectif de réduire ...” - GlaxoSmithKline FranceŒuvrer pour une société plus juste et plus équitable
“Amgen s.a.s. œuvre pour une société plus juste et ...” - Amgen France60% of similar organizations communicate on CSR issues
+2496 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports